XtalPi, a global leading AI- and robotics-driven drug discovery platform, today noted a key milestone in its collaboration with ReviR Therapeutics: dosing of the first participant in the Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results